canertinib has been researched along with Cancer of Colon in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brattain, MG; Foster, JM; Koterba, AP; Kreisberg, JI; Rajput, A; Willson, JK | 1 |
1 other study(ies) available for canertinib and Cancer of Colon
Article | Year |
---|---|
A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivo.
Topics: Animals; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Neoplasm; Enzyme Activation; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; Immunohistochemistry; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Morpholines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Signal Transduction; Transfection; Transforming Growth Factor alpha; Xenograft Model Antitumor Assays | 2007 |